Allogene Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Allogene Therapeutics, Inc.‘s stocks are currently a part of 102 hedge funds’ portfolios, which represents 23.55% of the total amount of its stocks outstanding. This makes up a total of 33.70M shares of Allogene Therapeutics, Inc.. Compared to the previous quarter, the number fell by -69.63% or -77.27M shares fewer. As for the holding position changes, 34.31% (35) of current hedge fund investors increased the number of shares held, 26.47% (27) of current holders sold a part of the shares held, and 9.8% (10) closed the holdings completely. 16 hedge funds are new holders of Allogene Therapeutics, Inc. stock in Q1 2023, it is 15.69% of total holders.
Hedge funds holding Allogene Therapeutics (Q1 2016 – Q1 2023)
| Q1 2016 | 1 |
|---|---|
| Q2 2016 | 0 |
| Q4 2018 | 79 |
| Q1 2019 | 86 |
| Q2 2019 | 95 |
| Q3 2019 | 95 |
| Q4 2019 | 115 |
| Q1 2020 | 113 |
| Q2 2020 | 172 |
| Q3 2020 | 160 |
| Q4 2020 | 162 |
| Q1 2021 | 167 |
| Q2 2021 | 179 |
| Q3 2021 | 166 |
| Q4 2021 | 170 |
| Q1 2022 | 174 |
| Q2 2022 | 156 |
| Q3 2022 | 179 |
| Q4 2022 | 162 |
| Q1 2023 | 102 |
Hedge funds changes in Allogene Therapeutics positions (Q1 2016 – Q1 2023)
| Q1 2016 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2016 | 0 | 0 | 0 | 1 | -1 |
| Q4 2018 | 79 | 0 | 0 | 0 | 0 |
| Q1 2019 | 19 | 29 | 19 | 12 | 7 |
| Q2 2019 | 25 | 37 | 20 | 12 | 1 |
| Q3 2019 | 11 | 38 | 25 | 11 | 10 |
| Q4 2019 | 31 | 38 | 26 | 12 | 8 |
| Q1 2020 | 15 | 40 | 36 | 16 | 6 |
| Q2 2020 | 68 | 55 | 37 | 8 | 4 |
| Q3 2020 | 28 | 56 | 55 | 37 | -16 |
| Q4 2020 | 21 | 71 | 44 | 18 | 8 |
| Q1 2021 | 33 | 45 | 62 | 27 | 0 |
| Q2 2021 | 40 | 82 | 29 | 27 | 1 |
| Q3 2021 | 18 | 53 | 55 | 29 | 11 |
| Q4 2021 | 38 | 68 | 40 | 32 | -8 |
| Q1 2022 | 34 | 69 | 42 | 30 | -1 |
| Q2 2022 | 14 | 62 | 49 | 28 | 3 |
| Q3 2022 | 36 | 63 | 49 | 12 | 19 |
| Q4 2022 | 23 | 64 | 50 | 37 | -12 |
| Q1 2023 | 16 | 35 | 27 | 10 | 14 |
Hedge funds changes in Allogene Therapeutics stock options (Q1 2016 – Q1 2023)
| Q1 2016 | 0 | 0 |
|---|---|---|
| Q2 2016 | 0 | 0 |
| Q4 2018 | 912,000 | 16,000 |
| Q1 2019 | 2,449,000 | 3,106,000 |
| Q2 2019 | 2,939,000 | 2,340,000 |
| Q3 2019 | 10,732,000 | 2,280,000 |
| Q4 2019 | 3,112,000 | 2,972,000 |
| Q1 2020 | 1,693,000 | 1,953,000 |
| Q2 2020 | 15,908,000 | 9,131,000 |
| Q3 2020 | 5,544,000 | 5,320,000 |
| Q4 2020 | 3,151,000 | 3,225,000 |
| Q1 2021 | 16,477,000 | 4,525,000 |
| Q2 2021 | 4,689,000 | 4,680,000 |
| Q3 2021 | 2,179,000 | 4,173,000 |
| Q4 2021 | 2,291,000 | 2,020,000 |
| Q1 2022 | 1,236,000 | 764,000 |
| Q2 2022 | 1,270,000 | 278,000 |
| Q3 2022 | 1,991,000 | 1,673,000 |
| Q4 2022 | 621,110 | 399,641 |
| Q1 2023 | 10,453,000 | 198,266,000 |